← Back to Search

Physical activity intervention for Colorectal Cancer (METS Trial)

N/A
Waitlist Available
Led By Heather Greenlee, ND, PhD
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Fluent in English or Spanish;
At high risk of developing colorectal cancer;
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights

METS Trial Summary

The purpose of this study has 2 aims: Aim 1: To demonstrate the feasibility of recruiting and retaining adults at high risk of colorectal cancer to a physical activity intervention trial. Investigators hypothesize that it will be possible to recruit and retain this patient population to a physical activity intervention trial. Aim 2: To demonstrate the feasibility of collecting, processing, storing stool samples and analyzing the gut microbiome data. Investigators hypothesize that all of these steps are feasible.

Eligible Conditions
  • Colorectal Cancer

METS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

METS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of participants retained at the end of study
Secondary outcome measures
Percentage of participants with collected, processed, and analyzed stool samples

METS Trial Design

1Treatment groups
Experimental Treatment
Group I: Physical activity interventionExperimental Treatment1 Intervention
Subjects at higher risk of developing colorectal cancer will maintain the current level of activity during the first 4 weeks and exercise 150 minutes per week during the last 4 weeks. During the entire study, subjects will wear a Fitbit device on their wrist.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Physical activity intervention
2009
N/A
~2960

Find a Location

Who is running the clinical trial?

Columbia UniversityLead Sponsor
1,424 Previous Clinical Trials
2,473,018 Total Patients Enrolled
Heather Greenlee, ND, PhDPrincipal InvestigatorColumbia University
3 Previous Clinical Trials
131 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~1 spots leftby Mar 2025